Glanbia Nutritionals Expands Partnership with Ganeden Biotech for Cosmetic Ingredient

Glanbia Nutritionals, a leading supplier of nutritional ingredients and provider of micronutrient premixes, has signed an agreement with Ganeden Biotech to represent their latest probiotic product, the topical anti-aging ingredient Bonicel. Under the terms of the agreement, Glanbia will serve as the primary distributor of Bonicel in North America.

1 Mar 2013 --- Bonicel has a number of anti-aging and cosmetic properties and has been shown to reduce the appearance of fine lines and wrinkles, improve skin elasticity and hydration, reduce skin inflammation and reduce under eye puffiness. In a recent human clinical trial, subjects reported a 50% reduction in fine lines and wrinkles, a 16% increase in skin hydration and an 11% improvement in skin elasticity.

Bonicel is the supernatant, or metabolic byproduct, of Ganeden’s popular shelf-stable probiotic GanedenBC30. Bonicel is produced during the bacterial fermentation that creates GanedenBC30 and contains an optimized combination of naturally derived metabolites.

“As a unique ingredient with an impressive array of clinically proven benefits, Bonicel is an excellent addition to our current product line,” said Lynda Doyle, Vice President of Business Development at Glanbia Nutritionals. “We are excited to expand upon our existing partnership with Ganeden and promote another of their quality, science-backed products.”

Commenting on the announcement, Michael Bush, Ganeden’s Vice President of Business Development, stated “We have achieved great success partnering with Glanbia on the promotion of GanedenBC30, and we look forward to a similar expansion of Bonicel into a variety of cosmetic products. Glanbia’s global sales force and leading position in the industry provide an excellent outlet for our latest innovative ingredient.”